Deltex Medical Regulatory News (DEMG)

9 Mar 2007 12:35

Deltex Medical Group PLC09 March 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to whichvoting rights are attached (ii): Deltex Medical Group Plc 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (No) An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached: (No) An event changing the breakdown of voting rights: (No) Other (please specify) : Initial notification of shareholding under TransparencyDirective 3. Full name of person(s) subject to the notification obligation (iii): Barclays PLC 4. Full name of shareholder(s) (if different from 3.) (iv): Barclays Shareholders Ltd Gerrard Ltd 5. Date of the transaction (and date on which the threshold is crossed orreached if different) (v): 6 March 2007 6. Date on which issuer notified: 8 March 2007 7. Threshold(s) that is/are crossed or reached: N/A 8. Notified details: ................. A: Voting rights attached to shares Class/type of shares if possible Situation previous to the Triggering transaction (vi)using the ISIN CODE Number of shares Number of voting Rights (viii) 4,515,383 4,515,383GB0059337583 Resulting situation after the triggering transaction (vii) Class/type of shares if Number of shares Number of voting rights (ix) % of voting rightspossible using the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect 4,646,039 0 4,646,039 0.00 5.60GB0059337583 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of Expiration Date Exercise/Conversion Number of voting rights % of voting rightsfinancial (xiii) Period/ Date (xiv) that may be acquired if theinstrument instrument is exercised/ converted. N/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights 4,646,039 5.60 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable (xv): Barclays Stockbrokers Ltd Gerrard Ltd Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: GEOFF SMITH 15. Contact telephone number: 020 7116 2913 This information is provided by RNS The company news service from the London Stock Exchange